The solution structure of the hepatitis C virus (BK strain) NS3 protein N-terminal domain (186 residues) has been solved by NMR spectroscopy. The protein is a serine protease with a chymotrypsin-type fold, and is involved in the maturation of the viral polyprotein. Despite the knowledge that its activity is enhanced by the action of a viral protein cofactor, NS4A, the mechanism of activation is not yet clear. The analysis of the folding in solution and the differences from the crystallographic structures allow the formulation of a model in which, in addition to the NS4A cofactor, the substrate plays an important role in the activation of the catalytic mechanism. A unique structural feature is the presence of a zinc-binding site exposed on t...
AbstractDuring replication of hepatitis C virus (HCV), the final steps of polyprotein processing are...
25 pags., 8 figs. -- This article belongs to the Collection Protein FoldingThe nonstructural protein...
We present the first structure of a noncovalent inhibitor bound to the protease domain of hepatitis ...
The solution structure of the hepatitis C virus (BK strain) NS3 protein N-terminal domain (186 resid...
The solution structure of the hepatitis C virus (BK strain) NS3 protein N-terminal domain (186 resid...
The solution structure of the hepatitis C virus (BK strain) NS3 protein N-terminal domain (186 resid...
The nonstructural protein 3 (NS3) from the hepatitis C virus (HCV) is responsible for processing the...
The NS3 region of the hepatitis C virus encodes for a serine protease activity, which is necessary f...
The NS3 region of the hepatitis C virus encodes for a serine protease activity, which is necessary f...
The NS3 region of the hepatitis C virus encodes for a serine protease activity, which is necessary f...
AbstractAn estimated 1% of the global human population is infected by hepatitis C viruses (HCVs), an...
The interactions of peptide inhibitors, obtained by the optimization of N-terminal cleavage products...
The interactions of peptide inhibitors, obtained by the optimization of N-terminal cleavage products...
The interactions of peptide inhibitors, obtained by the optimization of N-terminal cleavage products...
The interactions of peptide inhibitors, obtained by the optimization of N-terminal cleavage products...
AbstractDuring replication of hepatitis C virus (HCV), the final steps of polyprotein processing are...
25 pags., 8 figs. -- This article belongs to the Collection Protein FoldingThe nonstructural protein...
We present the first structure of a noncovalent inhibitor bound to the protease domain of hepatitis ...
The solution structure of the hepatitis C virus (BK strain) NS3 protein N-terminal domain (186 resid...
The solution structure of the hepatitis C virus (BK strain) NS3 protein N-terminal domain (186 resid...
The solution structure of the hepatitis C virus (BK strain) NS3 protein N-terminal domain (186 resid...
The nonstructural protein 3 (NS3) from the hepatitis C virus (HCV) is responsible for processing the...
The NS3 region of the hepatitis C virus encodes for a serine protease activity, which is necessary f...
The NS3 region of the hepatitis C virus encodes for a serine protease activity, which is necessary f...
The NS3 region of the hepatitis C virus encodes for a serine protease activity, which is necessary f...
AbstractAn estimated 1% of the global human population is infected by hepatitis C viruses (HCVs), an...
The interactions of peptide inhibitors, obtained by the optimization of N-terminal cleavage products...
The interactions of peptide inhibitors, obtained by the optimization of N-terminal cleavage products...
The interactions of peptide inhibitors, obtained by the optimization of N-terminal cleavage products...
The interactions of peptide inhibitors, obtained by the optimization of N-terminal cleavage products...
AbstractDuring replication of hepatitis C virus (HCV), the final steps of polyprotein processing are...
25 pags., 8 figs. -- This article belongs to the Collection Protein FoldingThe nonstructural protein...
We present the first structure of a noncovalent inhibitor bound to the protease domain of hepatitis ...